A variety of processes, including Aβ, impaired brain glucose metabolism, inflammation, and infection all play a part in abnormal tau hyperphosphorylation; therefore, identifying pathways governing post-translational modifications of tau may prove extremely valuable when searching for therapeutic targets. The gene discussed is MAPT; the disease is infection.